Results 21 to 30 of about 16,602 (194)
The value of ADC calculations in the assessment of the early response of hepatocellular carcinoma (HCC) to trans arterial catheter chemoembolization (TACE). [PDF]
Minia Journal of Medical Research, 2019 Transcatheter arterial chemoembolization (TACE) is a well-accepted method for Treatment of unresectable hepatocellular carcinoma (HCC). Determining the success of treatment by imaging studies would help to guide subsequent therapeutic planning ...
Kareem Megahed +2 more
doaj +1 more source
World Journal of Surgical Oncology, 2021 Background Transcatheter arterial chemoembolization has been widely used in patients with hepatocellular carcinoma. However, double blood supply and the existence of portal vein tumor thrombus influence the efficacy of transcatheter arterial ...
Zhiying Shao +4 more
doaj +1 more source
Enhanced radiofrequency ablation for recurrent hepatocellular carcinoma post-transarterial chemoembolization: a prospective study utilizing twin internally cooled-perfusion electrodes [PDF]
Journal of Liver CancerBackgrounds/Aims Radiofrequency ablation (RFA) is widely employed for managing recurrent hepatocellular carcinoma (HCC) following transarterial chemoembolization (TACE).
Sungjun Hwang +6 more
doaj +1 more source
Role of transarterial chemoembolization for hepatocellular carcinoma with extrahepatic metastases in the era of advancing systemic therapy [PDF]
Journal of Liver CancerBackgrounds/Aims Systemic therapy is the current standard treatment for hepatocellular carcinoma (HCC) with extrahepatic metastasis (EHM). However, some patients with HCC and EHM undergo transarterial chemoembolization (TACE) to manage intrahepatic ...
Byeong Geun Song +7 more
doaj +1 more source
Frontiers in Surgery, 2023 AimTo evaluate the feasibility of the preoperative neutrophil-to-lymphocyte ratio (NLR) as an index to guide postoperative adjuvant transcatheter arterial chemoembolization (PA-TACE) in patients with liver cancer.MethodsWe recruited a total of 166 patients with liver cancer who underwent surgery alone or surgery plus PA-TACE between January 2013 and ...
Guo-Ying Feng +7 more
openaire +3 more sources
Diffusion Kurtosis Imaging for Assessing the Therapeutic Response of Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma [PDF]
Journal of Cancer, 2020 Objective: This study aimed to evaluate the therapeutic response of hepatocellular carcinoma (HCC) after transcatheter arterial chemoembolization (TACE) with diffusion kurtosis imaging (DKI). Methods: Forty-three patients with fifty-nine hepatic cancer nodules were recruited for this study. All patients were treated by TACE. Magnetic resonance imaging (
Yuan, Zhen-Guo +6 more
openaire +2 more sources
Impact of Hyperglycemia on Complication and Mortality after Transarterial Chemoembolization for Hepatocellular Carcinoma [PDF]
Diabetes & Metabolism JournalBackground Current guidelines regarding periprocedural glycemic control to prevent complications after nonsurgical invasive procedures are insufficient.
Sun Joon Moon +3 more
doaj +1 more source
Cancer Medicine, 2023 Aims To investigate the efficacy and safety of lenvatinib and idarubicin‐loaded drug‐eluting beads transarterial chemoembolization (IDADEB‐TACE) in primary advanced hepatocellular carcinoma (HCC).
Wenzhe Fan +11 more
doaj +1 more source
World Journal of Gastroenterology, 2016 Hepatocellular carcinoma (HCC) is one of the major causes of morbidity and mortality in patients with chronic liver disease. Transarterial chemoembolization (TACE) can significantly improve the survival rate of patients with HCC and is the first treatment choice for patients who are not suitable for surgical resections.
Ke, Yang +4 more
openaire +2 more sources
Cancer Imaging, 2023 Purpose Raltitrexed shows therapeutic effects and safety in many types of malignant tumors. However, reports of the clinical outcomes of raltitrexed-based transarterial chemoembolization (TACE) or drug-eluting beads TACE (DEB-TACE) in the treatment of ...
Yonghua Bi +5 more
doaj +1 more source